Literature DB >> 1717618

Tumor necrosis factor and immunopathology.

P F Piguet1, G E Grau, P Vassalli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717618     DOI: 10.1007/bf02918160

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  101 in total

1.  Origin and nature of the cells participating in the popliteal graft versus host reaction in mouse and rat.

Authors:  P F Piguet; H K Dewey; P Vassalli
Journal:  Cell Immunol       Date:  1977-06-15       Impact factor: 4.868

2.  Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease.

Authors:  J L Ferrara; F J Guillen; P J van Dijken; A Marion; G F Murphy; S J Burakoff
Journal:  Transplantation       Date:  1989-01       Impact factor: 4.939

3.  Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected].

Authors:  L Chatenoud; C Ferran; A Reuter; C Legendre; Y Gevaert; H Kreis; P Franchimont; J F Bach
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

Review 4.  Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data.

Authors:  G E Grau; P F Piguet; P Vassalli; P H Lambert
Journal:  Immunol Rev       Date:  1989-12       Impact factor: 12.988

5.  Histologic studies on the hepatic lesions induced by graft-versus-host reaction in MHC class II disparate hosts compared with primary biliary cirrhosis.

Authors:  T Saitoh; M Fujiwara; M Nomoto; T Kamimura; K Ishihara; H Asakura
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

6.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

Authors:  C O Jacob; S Aiso; S A Michie; H O McDevitt; H Acha-Orbea
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Heterogeneous effects of IFN-gamma in adjuvant arthritis.

Authors:  C O Jacob; J Holoshitz; P Van der Meide; S Strober; H O McDevitt
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

8.  Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice.

Authors:  Y Aso; K Yoneda; Y Kikkawa
Journal:  Lab Invest       Date:  1976-12       Impact factor: 5.662

9.  Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-gamma.

Authors:  J Taverne; D C Rayner; P H Van der Meide; P M Lydyard; S P Bidey; A Cooke
Journal:  Eur J Immunol       Date:  1987-12       Impact factor: 5.532

10.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin.

Authors:  P F Piguet
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Titration of non-replicating adenovirus as a vector for transducing active TGF-beta1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice.

Authors:  G Sakuntala Warshamana; Derek A Pociask; Krishna J Fisher; Jing-Yao Liu; Patricia J Sime; Arnold R Brody
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

3.  Tumour necrosis factor receptor distribution in human lymphoid tissue.

Authors:  B Ryffel; M Brockhaus; B Greiner; M J Mihatsch; F Gudat
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

4.  Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria.

Authors:  J L Sarthou; G Angel; G Aribot; C Rogier; A Dieye; A Toure Balde; B Diatta; P Seignot; C Roussilhon
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Reduction of burn progression with topical delivery of (antitumor necrosis factor-α)-hyaluronic acid conjugates.

Authors:  Liang Tso Sun; Emily Friedrich; Joshua L Heuslein; Rachel E Pferdehirt; Nicole M Dangelo; Shanmugasundaram Natesan; Robert J Christy; Newell R Washburn
Journal:  Wound Repair Regen       Date:  2012-06-19       Impact factor: 3.617

6.  Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor.

Authors:  P F Piguet; G E Grau; C Vesin; H Loetscher; R Gentz; W Lesslauer
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

7.  Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.

Authors:  L Sekut; D Yarnall; S A Stimpson; L S Noel; R Bateman-Fite; R L Clark; M F Brackeen; J A Menius; K M Connolly
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

8.  Novel DNA polymorphism in the mouse tumor necrosis factor receptors type 1 and type 2.

Authors:  S Takao; K Mykytyn; C O Jacob
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

9.  Production of tumor necrosis factor, interleukin-6 and prostaglandin E2 by LPS-stimulated rat bone marrow macrophages after thermal injury: effect of indomethacin.

Authors:  C K Ogle; X Guo; K Szczur; S Hartmann; J D Ogle
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

10.  Acute ethanol consumption synergizes with trauma to increase monocyte tumor necrosis factor alpha production late postinjury.

Authors:  G Szabo; P Mandrekar; B Verma; A Isaac; D Catalano
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.